Therapeutic Effects of Short-Term Monochromatic Infrared Energy Therapy on Patients With Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Study

被引:15
|
作者
Hsieh, Ru-Lan [1 ,2 ]
Lo, Min-Tzu [3 ]
Lee, Wen-Chung [4 ]
Liao, Wei-Cheng [2 ]
机构
[1] Shin Kong Wu Ho Su Mem Hosp, Dept Phys Med & Rehabil, Taipei 11101, Taiwan
[2] Taipei Med Univ, Taipei, Taiwan
[3] Natl Taiwan Univ, Inst Epidemiol & Preventat Med, Taipei 10764, Taiwan
[4] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan
来源
关键词
International Classification of Functioning; Disability and Health; knee osteoarthritis; monochromatic infrared energy; therapeutic effect; DIABETIC PERIPHERAL NEUROPATHY; OUTCOME SCORE KOOS; HOSPITAL ANXIETY; LIGHT THERAPY; PAIN; VALIDATION; SENSATION; CLASSIFICATION; RELIABILITY; INSTRUMENT;
D O I
10.2519/jospt.2012.3881
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
STUDY DESIGN: Randomized, double-blind, placebo-controlled study. OBJECTIVES: To examine the short-term therapeutic effects of monochromatic infrared energy (MIRE) on participants with knee osteoarthritis (OA). Patients were assessed according to the International Classification of Functioning, Disability and Health. BACKGROUND: MIRE is commonly used in therapy for patients with peripheral neuropathies. However, research has not focused intensively on the therapeutic effects of MIRE in patients with knee OA. METHODS: This study enrolled 73 participants with knee OA. Participants received six 40-minute sessions of active or placebo MIRE treatment (890-nm wavelength; power, 6.24 W; energy density, 2.08 J/cm(2)/min; total energy, 83.2 J/cm(2)) over the knee joints for 2 weeks. International Classification of Functioning, Disability and Health related outcomes were collected weekly over 4 weeks using the Knee injury and Osteoarthritis Outcome Score, Lysholm Knee Scale, Hospital Anxiety and Depression Scale, Multidimensional Fatigue Inventory, Chronic Pain Grade questionnaire, World Health Organization Quality of Life-brief version, and OA Quality of Life Questionnaire. Data were analyzed by repeated-measures analysis of variance. RESULTS: No statistically significant differences were found for the interaction of group by time for Knee injury and Osteoarthritis Outcome Score scores, including pain, other symptoms, function in daily living, function in sport and recreation, and knee-related quality of life. Scores on the Lysholm Knee Scale, Hospital Anxiety and Depression Scale, Multidimensional Fatigue Inventory, Chronic Pain Grade questionnaire, World Health Organization Quality of Life-brief version, and OA Quality of Life Questionnaire also showed no significant differences between the 2 groups at any of the 4 follow-up assessments. CONCLUSION: Short-term MIRE therapy provided no beneficial effects to body functions, activities, participation, and quality of life in patients with knee OA. LEVEL OF EVIDENCE: Therapy, level 1b-.J Orthop Sports Phys Ther 2012;42(11):947-956, Epub 5 September 2012. doi:10.2519/jospt.2012.3881
引用
收藏
页码:947 / 956
页数:10
相关论文
共 50 条
  • [41] Combining two hyaluronic acids in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial
    Petrella, Robert J.
    Cogliano, Anthony
    Decaria, Joseph
    CLINICAL RHEUMATOLOGY, 2008, 27 (08) : 975 - 981
  • [42] The effect of short-term antidepressant treatment on gastric emptying: A double-blind, randomized, placebo-controlled trial
    Choung, Rok Seon
    Cremonini, Filippo
    Locke, G. Richard, III
    Thapa, Prabin
    Zinsmeister, Alan R.
    Talley, Nichoas J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 : 63 - 64
  • [43] Efficacy and safety of short-term itraconazole in tinea pedis: A double-blind, randomized, placebo-controlled trial
    Svejgaard, E
    Avnstorp, C
    Wanscher, B
    Nilsson, J
    Heremans, A
    DERMATOLOGY, 1998, 197 (04) : 368 - 372
  • [44] Is hyaluronate sodium effective in the management of knee osteoarthritis? A placebo-controlled double-blind study
    Kul-Panza, E.
    Berker, N.
    MINERVA MEDICA, 2010, 101 (02) : 63 - 72
  • [45] EFFICACY AND SAFETY OF ORAL SALMON CALCITONIN IN PATIENTS WITH KNEE OSTEOARTHRITIS: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Holm-Bentzen, M.
    Hoeck, H. C.
    Alexandersen, P.
    Valter, I.
    Hala, T.
    Radulescu, F.
    Jendrych, B.
    Badurski, J. E.
    Lau, E.
    John, M. R.
    Loeffler, J.
    Arnold, M.
    Riis, B. J.
    Christiansen, C.
    OSTEOARTHRITIS AND CARTILAGE, 2010, 18 : S252 - S252
  • [46] DHEP PLASTERS AS A TOPICAL TREATMENT OF KNEE OSTEOARTHRITIS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    DREISER, RL
    TISNECAMUS, M
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1993, 19 (03) : 117 - 123
  • [47] Magnetic pulse treatment for knee osteoarthritis: A randomised, double-blind, placebo-controlled study
    Pipitone, N
    Scott, DL
    CURRENT MEDICAL RESEARCH AND OPINION, 2001, 17 (03) : 190 - 196
  • [48] A RANDOMIZED DOUBLE-BLIND SHORT-TERM TRIAL OF TENOXICAM VERSUS PIROXICAM IN OSTEOARTHRITIS OF THE KNEE
    ALBALLA, SR
    ALNASSER, A
    ALARFAJ, H
    HAMOOH, Z
    ALSUGAIR, S
    SADDIQUE, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 47 (03): : 591 - 596
  • [49] Short-Term Soy Isoflavone Intervention in Patients with Localized Prostate Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
    Hamilton-Reeves, Jill M.
    Banerjee, Snigdha
    Banerjee, Sushanta K.
    Holzbeierlein, Jeffrey M.
    Thrasher, J. Brantley
    Kambhampati, Suman
    Keighley, John
    van Veldhuizen, Peter
    PLOS ONE, 2013, 8 (07):
  • [50] RANDOMIZED, DOUBLE-BLIND, SHORT-TERM TRIAL OF NABUMETONE VERSUS DICLOFENAC IN OSTEOARTHRITIS OF THE KNEE
    ALBALLA, SR
    ALARFAJ, H
    ALSUGAIR, S
    ALARFAJ, A
    ALSHAMMARI, SA
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 52 (04): : 581 - 586